Short-course treatments of streptococcal pharyngotonsillitis with oral cephalosporins and macrolides have resulted in a similar bacteriologic and clinical cure rate and in better compliance compared to the conventional 10-day course. Cefaclor has never been investigated for this purpose. 138 patients out of 420 recruited patients had a positive culture for S. pyogenes and were randomly assigned to receive cefaclor (25 mg/kg/bid) for a 5- (70 pts) or 10-day (68 pts) course. Patients were assessed clinically and bacteriologically 2-3 days after completing the course and followed up after 20-30 days. All 420 recruited patients belonged to a population of 2,800 children who had been previously screened for a streptococcal carrier state to exclude carriers from final evaluation. Clinical cure and bacteriological eradication was recorded in 92.8% and 92.6% of patients in groups A and B respectively. Therefore, short-course therapy with cefaclor may offer an effective alternative treatment to conventional regimens, with potential for better compliance.

Download full-text PDF

Source

Publication Analysis

Top Keywords

short-course therapy
8
clinical cure
8
better compliance
8
420 recruited
8
recruited patients
8
patients
6
[treatment streptococcal
4
streptococcal tonsillo-pharyngitis
4
tonsillo-pharyngitis paediatric
4
paediatric patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!